Compare OVID & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | ACR |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.5M | 139.5M |
| IPO Year | 2017 | N/A |
| Metric | OVID | ACR |
|---|---|---|
| Price | $1.60 | $18.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $3.40 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 1.7M | 25.3K |
| Earning Date | 03-10-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.65 |
| EPS | N/A | ★ 0.95 |
| Revenue | $6,610,000.00 | ★ $88,952,000.00 |
| Revenue This Year | $1,077.56 | $3.67 |
| Revenue Next Year | N/A | $1.87 |
| P/E Ratio | ★ N/A | $19.70 |
| Revenue Growth | ★ 945.89 | 14.87 |
| 52 Week Low | $0.24 | $16.51 |
| 52 Week High | $2.01 | $24.61 |
| Indicator | OVID | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | N/A |
| Support Level | $1.40 | N/A |
| Resistance Level | $1.61 | N/A |
| Average True Range (ATR) | 0.12 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 15.91 | 0.00 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.